A novel AI-based decision support system for insulin titration in type 2 diabetes reveals important considerations surrounding the feasibility of clinical implementation.
References
Guerron, A. D., Davis, G. M. & Pasquel, F. J. Endocrinol. Metab. Clin. North Am. 50, 457–474 (2021).
Lee, Y. B. et al. Diabetes Care 46, 959–966 (2023).
Lehmann, V. et al. Diabetes Care 46, 993–997 (2023).
Huang, J. et al. J. Diabetes Sci. Technol. 17, 224–238 (2023).
Wang, G. et al. Nat. Med. s41591-023-02552-9 (2023).
Shao, H., Shi, L., Lin, Y. & Fonseca, V. J. Diabetes Complications 36, 108316 (2022).
Kianmehr, H. et al. J. Diabetes Complications 36, 108287 (2022).
Tejedor, M., Woldaregay, A. Z. & Godtliebsen, F. Artif. Intell. Med. 104, 101836 (2020).
Aloi, J. et al. J. Diabetes Sci. Technol. 11, 12–16 (2017).
Neubauer, K. M. et al. Diabetes Technol. Ther. 17, 685–692 (2015).
Bode, B., Clarke, J. G. & Johnson, J. J. Diabetes Sci. Technol. 12, 124–128 (2018).
Sallam, M. Healthcare (Basel). 11, 887 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.M.D. reports research support from Insulet and consulting for Medscape. H.S. reports consulting for Eli Lilly, Sanofi and Johnson & Johnson. F.J.P. reports research support from Dexcom, Insulet, Novo Nordisk, Tandem and Ideal Medical Technologies and consulting for Dexcom and Medscape.
Rights and permissions
About this article
Cite this article
Davis, G.M., Shao, H. & Pasquel, F.J. AI-supported insulin dosing for type 2 diabetes. Nat Med 29, 2414–2415 (2023). https://doi.org/10.1038/s41591-023-02573-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02573-4
- Springer Nature America, Inc.